PRTN3 and rheumatoid arthritis: For example, certain studies suggested that EM was associated with seropositivity in women with early RA (176), and that MHT use could decrease the risk of ACPA+ RA in postmenopausal women >50 years of age, but not of ACPA- RA (177).